Deal overview

Deal overview
Target PRINCIPIA BIOPHARMA INC
Bidder SANOFI SA
Price £0.00 Full version or £25.00 Light version
Publication Date Aug 17, 2020
Abstract On 17 August 2020, the quoted French pharmaceutical company Sanofi SA ("Sanofi") announced a recommended cash offer for Principia Biopharma Inc ("Principia"), a Nasdaq listed biopharmaceutical company. The offer of $100 per share represented an aggregate equity value of approximately $3.68 billion (on a fully diluted basis). The offer was expected to commence later that ...
Number of pages (Full version) 0
Number of pages (Light version) 2
Format Adobe Acrobat (Download Acrobat Reader)
Free Sample Click Here to Download

Purchase this report

Accepted credit cards: Visa, America Express, Master Card

Buy and download this report in a fast a safe way using our secure payment system. We accept all major credit cards.

Search for Deals

Search over 70 million deal reports on more than 550,000 public and private companies. (copy)

Back to search results

Page Time: 0.013820s